Astrotech Corporation — Form 10-Q Summary
Period: The filing is for the quarter ended December 31, 2018, and covers the six months then ended. Although the request identifies “2017 Q2,” the filing itself reports fiscal 2019 Q2; comparisons below are with the periods ended December 31, 2017.
Business context
Astrotech develops and commercializes technology through two units: 1st Detect, which is developing trace detectors for explosives and narcotics, and Astral Images, which develops film-restoration software. Management is prioritizing 1st Detect; Astral headcount and spending are minimized because its market has developed more slowly than expected.
Financial performance and liquidity
| Metric (USD thousands, except per-share data) | Three months ended Dec. 31, 2018 | Three months ended Dec. 31, 2017 | Six months ended Dec. 31, 2018 | Six months ended Dec. 31, 2017 |
|---|---|---|---|---|
| Revenue | 7 | 41 | 40 | 41 |
| Gross profit / margin | 7 / 100% | 17 / 41% | 29 / 73% | 17 / 41% |
| Operating expenses | 2,183 | 3,184 | 4,430 | 6,260 |
| Operating loss | (2,176) | (3,167) | (4,401) | (6,243) |
| Net loss | (2,160) | (3,137) | (4,398) | (6,143) |
| Net loss per share | (0.46) | (0.77) | (1.01) | (1.51) |
- Revenue was very limited and came from Astral’s ColorTime agreement, which the company describes as discontinued. The prior-year quarter’s revenue came from a software license for work on one film.
- For the six months, operating expenses fell 29%: SG&A declined 20% and R&D declined 38%, primarily due to lower headcount and, for R&D, lower depreciation. The net loss narrowed by $1.745 million year over year.
- Cash used in operations was $4.230 million for the six months, versus $5.849 million a year earlier. Investing activities provided $3.597 million, mainly from investment sales and maturities; financing provided $2.927 million, primarily from the October equity placement.
- At December 31, cash and cash equivalents were $2.846 million; working capital was approximately $2.1 million. Total assets were $3.766 million and total liabilities $1.116 million. No borrowings are separately reported on the balance sheet; the filing does not provide a clear debt total.
- The company held no investments at December 31, compared with $3.551 million in short-term investments and $50,000 in long-term investments at June 30. No income tax benefit was recorded; deferred tax assets were fully reserved with a valuation allowance.
Material changes, outlook, and risks
- The October 9, 2018 private placement raised approximately $3.0 million gross, or $2.921 million net. It included preferred shares issued to the CEO/Chairman and common shares issued to another investor; the preferred shares converted into common shares on December 7 following shareholder approval.
- By February 8, 2019, the company had also sold 93,393 shares through its ATM program, receiving approximately $461,000 net at a weighted-average price of $5.08 per share.
- Management states that recurring losses and operating cash use raise substantial doubt about the company’s ability to continue as a going concern. It is evaluating additional funding options, including equity or debt financing, a sale, merger, or strategic partnership. Funding may not be available on acceptable terms; without it, the company may delay or reduce R&D, limit opportunities, or curtail operations.
- 1st Detect’s TRACER 1000 passed ECAC testing for passenger checkpoint screening in December 2018 and cargo screening in January 2019. Official ECAC certification was expected in the near term, but was not yet reported as granted. TSA passenger and cargo testing was described as progressing as expected. Sales to the airport market require TSA or ECAC certification, and approval is not assured.
- No financial forecasts or quantified sales guidance are provided. Management identifies risks including liquidity and going concern, regulatory approval, product acceptance, competition, government procurement and funding, and technical-development milestones.
- The filing reports no material pending legal proceedings and no off-balance-sheet arrangements. Management concluded disclosure controls were effective and reported no material change in internal control over financial reporting during the six-month period.
Investor verification points
- Confirm the actual filing period: the document is for the quarter ended December 31, 2018, not 2017 Q2.
- Track cash burn, available financing, ATM issuance, and share-count dilution; assess the company’s stated going-concern uncertainty.
- Verify whether ECAC certification was ultimately granted and whether TSA testing led to approval, commercial orders, and meaningful revenue.
- Assess whether cost reductions are sustainable and whether either business unit can generate revenue at a scale sufficient to fund operations.
- Review subsequent filings for updated liquidity, financing terms, contingent liabilities, and changes in management’s outlook.